EyeBio Revenue and Competitors
Estimated Revenue & Valuation
- EyeBio's estimated annual revenue is currently $2.6M per year.
- EyeBio's estimated revenue per employee is $54,896
- EyeBio's total funding is $130M.
Employee Data
- EyeBio has 48 Employees.
- EyeBio grew their employee count by 37% last year.
EyeBio's People
Name | Title | Email/Phone |
---|---|---|
1 | Executive Assistant to Chief Medical Officer | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | SVP Clinical Development | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | VP Quality Assurance | Reveal Email/Phone |
6 | SVP Biology | Reveal Email/Phone |
7 | Director, Regional Monitoring (US) | Reveal Email/Phone |
8 | Associate Director, Drug Supply | Reveal Email/Phone |
9 | Director, CMC Drug Substance | Reveal Email/Phone |
10 | Senior Data Manager | Reveal Email/Phone |
EyeBio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.2M | 16 | 23% | N/A | N/A |
#2 | $11.8M | 74 | 7% | N/A | N/A |
#3 | $1.8M | 23 | 35% | N/A | N/A |
#4 | $2.2M | 25 | -11% | N/A | N/A |
#5 | $1.8M | 18 | -5% | N/A | N/A |
#6 | $0.9M | 15 | 50% | N/A | N/A |
#7 | $0.1M | 1 | 0% | N/A | N/A |
#8 | $18.3M | 118 | -3% | N/A | N/A |
#9 | $0.5M | 7 | 40% | N/A | N/A |
#10 | $4.8M | 62 | 41% | N/A | N/A |
What Is EyeBio?
EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.
keywords:N/A$130M
Total Funding
48
Number of Employees
$2.6M
Revenue (est)
37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.6M | 48 | 26% | N/A |
#2 | $8.1M | 48 | -8% | N/A |
#3 | $5.1M | 48 | -17% | $3.8M |
#4 | $10.4M | 48 | -16% | N/A |
#5 | $9.6M | 48 | 2% | N/A |